We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.3B
AUM Growth
-$345M
(-0.94%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
771
New
91
Increased
196
Reduced
345
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$124M |
| 2 |
Merck
MRK
|
+$118M |
| 3 |
PNC Financial Services
PNC
|
+$109M |
| 4 |
STJ
St Jude Medical
STJ
|
+$108M |
| 5 |
Johnson Controls International
JCI
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$191M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$184M |
| 3 |
American Airlines Group
AAL
|
+$181M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$170M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.24% |
| 2 | Technology | 11.85% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fortive
FTV
$17.9B
| $23.9M | 0.07% |
+743,963
| New | +$23.9M |
|
|
SPNC
352
DELISTED
Spectranetics Corp
SPNC
| $23.8M | 0.07% |
950,000
-300,000
| -24% | -$7M |
|
353
Ameriprise Financial
AMP
$48.3B
| $23.7M | 0.07% |
237,167
-13,600
| -5% | -$1.32M |
|
354
Equifax
EFX
$20.3B
| $23.5M | 0.06% |
174,300
-2,400
| -1% | -$318K |
|
|
GGP
355
DELISTED
GGP Inc.
GGP
| $23.4M | 0.06% |
848,200
-14,700
| -2% | -$439K |
|
356
Asbury Automotive
ABG
$4.31B
| $22.7M | 0.06% |
407,947
| – | – |
|
|
TLN
357
DELISTED
Talen Energy Corporation
TLN
| $22.6M | 0.06% |
1,632,068
| – | – |
|
358
United Airlines
UAL
$39.4B
| $22.4M | 0.06% |
427,500
-99,400
| -19% | -$4.78M |
|
359
Huntington Bancshares
HBAN
$34.4B
| $22.3M | 0.06% |
+2,265,200
| New | +$21.6M |
|
360
TSMC
TSM
$2.1T
| $22M | 0.06% |
720,642
-229,000
| -24% | -$6.55M |
|
361
Genuine Parts
GPC
$17.1B
| $21.8M | 0.06% |
217,055
+9,100
| +4% | +$923K |
|
|
LOXO
362
DELISTED
Loxo Oncology, Inc
LOXO
| $21.4M | 0.06% |
817,500
| – | – |
|
|
RHT
363
DELISTED
Red Hat Inc
RHT
| $21.3M | 0.06% |
263,800
+12,700
| +5% | +$945K |
|
364
Cencora
COR
$60.6B
| $21.3M | 0.06% |
263,300
-10,800
| -4% | -$926K |
|
365
CSX Corp
CSX
$93.4B
| $21.2M | 0.06% |
2,084,004
+1,180,500
| +131% | +$11.2M |
|
366
Essex Property Trust
ESS
$18.3B
| $21.2M | 0.06% |
95,000
-1,300
| -1% | -$296K |
|
|
AVXS
367
DELISTED
AveXis, Inc. Common Stock
AVXS
| $21.1M | 0.06% |
512,931
-125,000
| -20% | -$4.75M |
|
368
Skyworks Solutions
SWKS
$9.37B
| $21M | 0.06% |
276,000
-9,100
| -3% | -$634K |
|
369
Medpace
MEDP
$16.1B
| $20.9M | 0.06% |
+700,000
| New | +$20.4M |
|
|
LLTC
370
DELISTED
Linear Technology Corp
LLTC
| $20.8M | 0.06% |
350,100
+91,000
| +35% | +$5.1M |
|
371
AngloGold Ashanti
AU
$40.1B
| $20.7M | 0.06% |
1,300,000
+1,000,000
| +333% | +$19M |
|
|
ORBC
372
DELISTED
ORBCOMM, Inc.
ORBC
| $20.6M | 0.06% |
2,010,263
+587,735
| +41% | +$6M |
|
|
MJN
373
DELISTED
Mead Johnson Nutrition Company
MJN
| $20.6M | 0.06% |
260,401
-11,000
| -4% | -$938K |
|
374
Ulta Beauty
ULTA
$22B
| $20.5M | 0.06% |
86,300
-3,500
| -4% | -$884K |
|
375
Expedia Group
EXPE
$35.4B
| $20.5M | 0.06% |
175,900
+3,300
| +2% | +$373K |
|
Similar funds
Adage Capital Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Adage Capital Partners held 771 positions worth $36.3B, down 0.94% from $36.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Adage Capital Partners withdrew a net $1.99B in Q3 2016, closing 92 positions and reducing 345 holdings. Its most notable exit was MEDIVATION, INC., an estimated $170M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Kinder Morgan worth $64.8M.
- Adage Capital Partners's largest Q3 2016 buy was Kinder Morgan: 2,802,197 shares worth $64.8M.
- Adage Capital Partners added most to CF Industries in Q3 2016, an estimated $124M increase.
- Adage Capital Partners's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $191M.
- Adage Capital Partners fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $170M.
- Adage Capital Partners's ten largest holdings make up 13% of its $36.3B portfolio in Q3 2016.
- Adage Capital Partners opened 91 new positions and closed 92 in Q3 2016.
- Adage Capital Partners's portfolio value fell 0.94% quarter-over-quarter to $36.3B.
Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.